Listen to The Lancet Global Health

Mandip Aujla from The Lancet Global Health speaks to Shona Dalal about her study, which estimates the risk of cervical cancer among women living with HIV and provides global estimates of the proportion of women with cervical cancer living with HIV.

Mandip Aujla from The Lancet Global Health speaks to Ashish KC about his study looking at the effect of the COVID-19 pandemic response on intrapartum care, stillbirth, and neonatal mortality outcomes in Nepal.

Nina Putnis of TLGH talks to authors Peter Waiswa and Dilys Walker about their research reducing stillbirths and neonatal death in Uganda and Kenya.

Nina Putnis from The Lancet Global Health discusses resource requirements and essential services for Universal Health Coverage (UHC) with Dr David Watkins, including implications for low-income countries, the importance of political will, and what this means in the context of COVID-19.

Nina Putnis from The Lancet Global Health speaks to Dr Emma Slaymaker from the LSHTM about her research on Sexual And Reproductive Health and Rights and global changes since the first International Conference on Population and Development 25 years ago

Mandip Aujla from The Lancet Global Health speaks to Andreas Alga about his study comparing negative pressure wound therapy with standard treatment in patients with acute conflict-related extremity wounds.

The Lancet Global Health's Nina Putnis speaks to Wietse Tol about his research on reducing psychological distress in female South Sudanese refugees, and the implications of this research for refugees and displaced people worldwide.

Mandip Aujla of The Lancet Global Health speaks to Luke Allen about his geopolitical analysis of the implementation of WHO-recommended NCD policies in 151 countries.

Nina Putnis of The Lancet Global Health speaks to Jonathan Abuga about his research on the risk factors for and causes of premature mortality in children with neurological impairments in Kilifi, Kenya.

Nina Putnis of The Lancet Global Health speaks to Amat Bah and Andrew Prentice about their randomised-controlled trial looking at a screen-and-treat model for iron deficient pregnant women in this West African country.